Natalya Davies
Stock Analyst at Rothschild & Co Redburn
(2.19)
# 3,028
Out of 4,429 analysts
9
Total ratings
44.4%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Natalya Davies
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintained: Buy | $179 | $115.48 | +55.01% | 1 | Apr 17, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $160 | $126.57 | +26.41% | 1 | Apr 17, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $575 → $620 | $464.01 | +33.62% | 2 | Apr 17, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €285.00 | $213.10 | +33.74% | 1 | Apr 17, 2026 | |
| BRKR Bruker | Maintained: Buy | $60 | $56.53 | +6.14% | 2 | Nov 20, 2025 | |
| A Agilent Technologies | Initiated Coverage: Buy | $165 | $126.49 | +30.45% | 1 | Oct 8, 2025 | |
| WAT Waters | Initiated Coverage: Buy | $390 | $358.25 | +8.86% | 1 | Oct 8, 2025 |
Merck & Co.
Apr 17, 2026
Maintained: Buy
Price Target: $179
Current: $115.48
Upside: +55.01%
Repligen
Apr 17, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $126.57
Upside: +26.41%
Thermo Fisher Scientific
Apr 17, 2026
Maintained: Buy
Price Target: $575 → $620
Current: $464.01
Upside: +33.62%
Sartorius Aktiengesellschaft
Apr 17, 2026
Maintained: Buy
Price Target: €285.00
Current: $213.10
Upside: +33.74%
Bruker
Nov 20, 2025
Maintained: Buy
Price Target: $60
Current: $56.53
Upside: +6.14%
Agilent Technologies
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $165
Current: $126.49
Upside: +30.45%
Waters
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $390
Current: $358.25
Upside: +8.86%